Carlyle »

Medline shares owned by Carlyle

Quarter-by-quarter ownership of Medline (MDLN) shares owned by Carlyle from 13F filings

Historical chart of Carlyle investment in Medline

Tip: Access up to 7 years of quarterly data

All positions including Medline held by Carlyle consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medline by Carlyle

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.0B 215M 42.00

More positions owned by Carlyle

Medline Com Cl A (MDLN)
Standardaero (SARO)
Phathom Pharmaceuticals (PHAT)
Pony Ai Sponsored Ads (PONY)
Invitation Homes (INVH)
Getty Images Holdings Cl A Com (GETY)
Cubesmart (CUBE)
Q32 Bio (QTTB)
Spruce Biosciences Com New (SPRB)
Forward Air Corp (FWRD)
Jasper Therapeutics Com New (JSPR)
Adicet Bio Com New (ACET)
Krispy Kreme (DNUT)
Onkure Therapeutics Com Cl A (OKUR)
N-able Common Stock (NABL)

View all positions for Carlyle

Top funds holding Medline

Carlyle
H&F Corporate Investors X
Vanguard Group
Capital Research Global Investors
Baillie Gifford & Co
Massachusetts Financial Services
WCM Investment Management
T. Rowe Price Investment Management
Viking Global Investors
Durable Capital Partners
Norges Bank Investment Management
Artisan Partners Limited Partnership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capital World Investors
Geode Capital Management

View all funds holding Medline